Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Nalrexone Facilitated Discontinuation of Buprenorphine

New York State Psychiatric Institute · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
stable opioid dependence, maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860090
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.